{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:47:15Z","timestamp":1775796435283,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10067-026-08043-9","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T01:38:33Z","timestamp":1773538713000},"page":"2463-2470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of interstitial lung disease in patients with psoriatic arthritis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5137-5998","authenticated-orcid":false,"given":"Pannathorn","family":"Nakaphan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-0686","authenticated-orcid":false,"given":"Varote","family":"Shotelersuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5647-346X","authenticated-orcid":false,"given":"Patavee","family":"Pajareya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-6020","authenticated-orcid":false,"given":"Noppachai","family":"Siranart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4199-1731","authenticated-orcid":false,"given":"Sarah","family":"Ifteqar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"issue":"12","key":"8043_CR1","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/rheumatology\/keae198","volume":"63","author":"S Lembke","year":"2024","unstructured":"Lembke S, Macfarlane GJ, Jones GT (2024) The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis. Rheumatology (Oxford) 63(12):3211\u20133220. https:\/\/doi.org\/10.1093\/rheumatology\/keae198","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8043_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11739-020-02451-8","volume":"16","author":"E Bargagli","year":"2021","unstructured":"Bargagli E, Bellisai F, Mazzei MA, Conticini E, Alderighi L, Cameli P et al (2021) Interstitial lung disease associated with psoriatic arthritis: a new disease entity? Intern Emerg Med 16(1):229\u2013231. https:\/\/doi.org\/10.1007\/s11739-020-02451-8","journal-title":"Intern Emerg Med"},{"issue":"10","key":"8043_CR3","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s00296-024-05685-3","volume":"44","author":"VS Schafer","year":"2024","unstructured":"Schafer VS, Winter L, Skowasch D, Bauer CJ, Pizarro C, Weber M et al (2024) Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study. Rheumatol Int 44(10):1975\u20131986. https:\/\/doi.org\/10.1007\/s00296-024-05685-3","journal-title":"Rheumatol Int"},{"key":"8043_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14165632","author":"A Delle Sedie","year":"2025","unstructured":"Delle Sedie A, Carli L, Varrecchia A, Cigolini C, Di Battista M, Esti L et al (2025) Interstitial lung disease: does it represent a real comorbidity in spondyloarthritis patients? Results from an ultrasound monocentric pilot study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14165632","journal-title":"J Clin Med"},{"issue":"22","key":"8043_CR5","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr.","year":"2014","unstructured":"King TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK et al (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370(22):2083\u20132092. https:\/\/doi.org\/10.1056\/NEJMoa1402582","journal-title":"N Engl J Med"},{"issue":"22","key":"8043_CR6","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370(22):2071\u20132082. https:\/\/doi.org\/10.1056\/NEJMoa1402584","journal-title":"N Engl J Med"},{"issue":"18","key":"8043_CR7","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"key":"8043_CR8","doi-asserted-by":"publisher","unstructured":"Cui Y, Han X, Dong S, Meng X, Sun C (2025) Drug-induced interstitial lung disease: a real-world pharmacovigilance study based on an adverse event reporting system. Respiration 1\u201315. https:\/\/doi.org\/10.1159\/000549124","DOI":"10.1159\/000549124"},{"issue":"6","key":"8043_CR9","first-page":"727","volume":"19","author":"J Belzunegui","year":"2001","unstructured":"Belzunegui J, Intxausti JJ, De Dios JR, Lopez-Dominguez L, Queiro R, Gonzalez C et al (2001) Absence of pulmonary fibrosis in patients with psoriatic arthritis treated with weekly low-dose methotrexate. Clin Exp Rheumatol 19(6):727\u2013730","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"8043_CR10","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10067-011-1765-7","volume":"30","author":"F Rondon","year":"2011","unstructured":"Rondon F, Mendez O, Spinel N, Ochoa C, Saavedra C, Penaranda E et al (2011) Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review. Clin Rheumatol 30(10):1379\u20131384. https:\/\/doi.org\/10.1007\/s10067-011-1765-7","journal-title":"Clin Rheumatol"},{"issue":"3\u20134","key":"8043_CR11","first-page":"154","volume":"18","author":"F Atzeni","year":"2016","unstructured":"Atzeni F, Grillo E, Masala IF, Sarzi-Puttini P, Jones GT (2016) Do anti-TNF blockers increase the risk of lung involvement in patients with ankylosing spondylitis or psoriatic arthritis? A systematic review. Isr Med Assoc J 18(3\u20134):154\u2013155","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"8043_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2424338","volume":"35","author":"S Kaburaki","year":"2024","unstructured":"Kaburaki S, Okada N, Tanaka T, Kamio K, Tanaka Y, Terasaki Y et al (2024) Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy. J Dermatolog Treat 35(1):2424338. https:\/\/doi.org\/10.1080\/09546634.2024.2424338","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"8043_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mayocpiqo.2018.07.006","volume":"2","author":"H Kawamoto","year":"2018","unstructured":"Kawamoto H, Hara H, Minagawa S, Numata T, Araya J, Kaneko Y et al (2018) Interstitial pneumonia in psoriasis. Mayo Clin Proc Innov Qual Outcomes 2(4):370\u2013377. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2018.07.006","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"1","key":"8043_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01381-z","volume":"21","author":"TH Barker","year":"2021","unstructured":"Barker TH, Migliavaca CB, Stein C, Colpani V, Falavigna M, Aromataris E et al (2021) Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol 21(1):189. https:\/\/doi.org\/10.1186\/s12874-021-01381-z","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"8043_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaf059","volume":"9","author":"A Engel","year":"2025","unstructured":"Engel A, Xie C, Summer R, Loizidis G (2025) The risk of interstitial lung disease in psoriatic arthritis versus psoriasis: a retrospective nationwide database analysis (2014-24). Rheumatol Adv Pract 9(3):rkaf059. https:\/\/doi.org\/10.1093\/rap\/rkaf059","journal-title":"Rheumatol Adv Pract"},{"issue":"11","key":"8043_CR16","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.55563\/clinexprheumatol\/iqfq8c","volume":"43","author":"B Monosi","year":"2025","unstructured":"Monosi B, Cristiano I, Capparelli E, Cito A, Conigliaro P, Lepri G et al (2025) Lung involvement in psoriatic arthritis patients: cross-sectional study on prevalence, clinical characteristics, and risk factors of a neglected comorbidity. Clin Exp Rheumatol 43(11):1888\u20131896. https:\/\/doi.org\/10.55563\/clinexprheumatol\/iqfq8c","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"8043_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.46497\/ArchRheumatol.2024.10537","volume":"39","author":"M Hunur","year":"2024","unstructured":"Hunur M, Ogut TS, Celik E, Erbasan F, Dilbil M, Nokay M et al (2024) Lung involvement in patients with psoriatic arthritis. Arch Rheumatol 39(4):631\u2013640. https:\/\/doi.org\/10.46497\/ArchRheumatol.2024.10537","journal-title":"Arch Rheumatol"},{"issue":"1","key":"8043_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03450-7","volume":"24","author":"N Kanaji","year":"2024","unstructured":"Kanaji N, Misaki N, Murota M, Iwata M, Ishikawa R, Yamamura K et al (2024) Prevalence and clinical features of interstitial lung disease in patients with psoriasis. BMC Pulm Med 24(1):610. https:\/\/doi.org\/10.1186\/s12890-024-03450-7","journal-title":"BMC Pulm Med"},{"issue":"9","key":"8043_CR19","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/1756-185X.13657","volume":"22","author":"S Yan","year":"2019","unstructured":"Yan S, Cui Y, Zhang X, Zhang G, Dong G, Feng Y et al (2019) The incidence of extra-articular manifestations in southern Chinese patients with inflammatory joint diseases. Int J Rheum Dis 22(9):1686\u20131694. https:\/\/doi.org\/10.1111\/1756-185X.13657","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"8043_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10067-014-2652-9","volume":"34","author":"R Peluso","year":"2015","unstructured":"Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, Di Minno MN (2015) Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol 34(4):745\u2013753. https:\/\/doi.org\/10.1007\/s10067-014-2652-9","journal-title":"Clin Rheumatol"},{"key":"8043_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5919304","volume":"2019","author":"G Ishikawa","year":"2019","unstructured":"Ishikawa G, Dua S, Mathur A, Acquah SO, Salvatore M, Beasley MB et al (2019) Concomitant interstitial lung disease with psoriasis. Can Respir J 2019:5919304. https:\/\/doi.org\/10.1155\/2019\/5919304","journal-title":"Can Respir J"},{"key":"8043_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108285","volume":"248","author":"S Mitchell","year":"2025","unstructured":"Mitchell S, Peterson JA, Seely M, Gao H, Hochhegger B, Patel DC et al (2025) Psoriasis-associated lung disease: a comprehensive review and case series. Respir Med 248:108285. https:\/\/doi.org\/10.1016\/j.rmed.2025.108285","journal-title":"Respir Med"},{"issue":"1","key":"8043_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05751-w","volume":"45","author":"L Winter","year":"2024","unstructured":"Winter L, Petzinna SM, Skowasch D, Pizarro C, Weber M, Kutting D et al (2024) Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study. Rheumatol Int 45(1):3. https:\/\/doi.org\/10.1007\/s00296-024-05751-w","journal-title":"Rheumatol Int"},{"issue":"11","key":"8043_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3899\/jrheum.2024-0252","volume":"51","author":"SA Provan","year":"2024","unstructured":"Provan SA, Ljung L, Kristianslund EK, Michelsen B, Uhlig T, Jonmundsson T et al (2024) Interstitial lung disease in patients with rheumatoid arthritis or psoriatic arthritis initiating biologics and controls: data from 5 Nordic registries. J Rheumatol 51(11):1111\u20131118. https:\/\/doi.org\/10.3899\/jrheum.2024-0252","journal-title":"J Rheumatol"},{"key":"8043_CR25","doi-asserted-by":"publisher","unstructured":"Ikdahl E, Mangseth H (2025) Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening. Scand J Rheumatol 1-9. https:\/\/doi.org\/10.1080\/03009742.2025.2538946","DOI":"10.1080\/03009742.2025.2538946"},{"issue":"2","key":"8043_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-05789-4","volume":"45","author":"H Prasanna","year":"2025","unstructured":"Prasanna H, Inderjeeth CA, Nossent JC, Almutairi KB (2025) The global prevalence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol Int 45(2):34. https:\/\/doi.org\/10.1007\/s00296-025-05789-4","journal-title":"Rheumatol Int"},{"key":"8043_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59091650","author":"G Rizzetto","year":"2023","unstructured":"Rizzetto G, Tagliati C, Fogante M, Marcucci M, Argalia G, Lanni G et al (2023) CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study. Medicina Kaunas. https:\/\/doi.org\/10.3390\/medicina59091650","journal-title":"Medicina Kaunas"},{"issue":"7","key":"8043_CR28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10067-011-1692-7","volume":"30","author":"M Khraishi","year":"2011","unstructured":"Khraishi M, MacDonald D, Rampakakis E, Vaillancourt J, Sampalis JS (2011) Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clin Rheumatol 30(7):877\u2013885. https:\/\/doi.org\/10.1007\/s10067-011-1692-7","journal-title":"Clin Rheumatol"},{"issue":"3","key":"8043_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/rheumatology\/keaa448","volume":"60","author":"L Pina Vegas","year":"2021","unstructured":"Pina Vegas L, Sbidian E, Penso L, Claudepierre P (2021) Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database. Rheumatology (Oxford) 60(3):1243\u20131251. https:\/\/doi.org\/10.1093\/rheumatology\/keaa448","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08043-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08043-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08043-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:49:02Z","timestamp":1775792942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08043-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8043"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08043-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is a systematic review and meta-analysis of previously published studies. No new data involving human participants or animals were collected.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}